Panchabhai, S
Schlam, I
Sebastian, S
Fonseca, R
Article History
First Online: 27 December 2016
Competing interests
: RF has sponsored research from AMGEN, Celgene, Onyx and Sanofi. He has received consulting fees from Bayer, Novartis, Onyx, Pharmacyclics, Sanofi and serves on the advisory committee of Applied Biosciences. He has received a patent for the prognostication of MM based on genetic categorization of the disease. The remaining authors declare no conflict of interest.